Broadstone Net Lease Priced 13M Share Public Offering of Common Stock @$21.35/Share
Broadstone Net Lease, Inc. (NYSE: BNL), ("BNL"), today announced the pricing of an underwritten public offering of 13,000,000 shares of its Common Stock, at a price to the public of $21.35 per share, less underwriting discounts and commissions, in connection with the forward sale agreements described below.
Athenex Priced ~35.55M Share/Warrant Public Offering @$0.749/Share/Warrant
Athenex, Inc. ("Athenex") (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced the pricing of its underwritten public offering of 35,333,334 shares of its common stock and accompan
LSB Industries Shares Drop Following Secondary Offering
Affiliates of Eldridge Industries LLC intend to sell a total of 13.5 million shares of LSB Industries, Inc. (NYSE:LXU) in a…
Allegiant Travel Commences $500M Debt Offering
Allegiant Travel Co (NASDAQ:ALGT) commenced an offering of $500 million of Senior Secured Notes due 2027 to investors in a private…
Biotech Daily: Cancer Causing Impurities In Merck’s Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon’s Monkeypox Trial
Here's a roundup of top developments in the biotech space over the last 24 hours:
Karuna Therapeutics Priced ~3.489M Share Public Offering of Common Stock @$215/Share
Karuna Therapeutics, Inc. (NASDAQ: KRTX) announced the pricing of an upsized underwritten public offering of 3,488,373 shares of its common stock at a public offering price of $215.00 per share.
Mirum Pharmaceuticals Priced 3.478M Share Public Offering of Common Stock @$23/Share
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) announced the pricing of its previously announced underwritten public offering of 3,478,261 shares of its common stock at a price to the public of $23.00 per share.